CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Articles
When & How to Use Changed Clinical Laboratory Consult Codes
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Liquid Biopsy Can Rule Out Need for Chemotherapy After Stage II Colon Cancer Surgery
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
White House Asks Congress to Get Moving on COVID-19 Relief Funding
The Biden administration released another statement on Wednesday reminding lawmakers of the consequences of not resolving the issue quickly.
Non-COVID Products Help Drive QIAGEN Q1 2022 Growth
Assay tech company shares that its Q1 2022 results were better than expected in spite of declines in COVID-19 product sales.
RHCA Would Expand Medicare Coverage of Genetic Cancer Screening
Recently introduced bill would require coverage of genomic cancer testing and follow-up screening for certain at-risk individuals.
Ransomware Attacks Expose Labs to Costly Negligence Lawsuits
With cyberattacks in the health care industry on the rise, it’s more important than ever for labs to protect patient information.
Labs in Court Weekly Roundup
False and fraudulent claims, particularly those relating to COVID-19 and telemedicine, made up most of the key enforcement actions announced by the DOJ this past week
Congress Moves to Expand Medicare Coverage of Genetic Cancer Screening
Senators recently introduced a bill that would require coverage for individuals with a family history of hereditary cancer.
Global DTC Genetic Testing Market to Top $1.9B by 2026
Even when accounting for the impact of COVID-19, recent report suggests the future of direct-to-consumer genetic testing remains bright.
Research Shows Race May Affect Interpretation of Alzheimer’s Blood Tests
Study finds that three out of four blood tests produced different results depending on if they were used for White or Black people.
DOJ Nabs 21 Defendants for COVID-19 Fraud
The DOJ recently charged defendants in nine different US districts for allegedly carrying out COVID-19 scams worth just over $149 million.
Cardiovascular Genetic Testing Guidelines Get a Technology Makeover
Guidelines on use of genetic testing for inherited cardiovascular diseases have been revised in accordance with 2022 testing technology.
